SCHEMBL3609796

SCHEMBL3609796

Cc1cc(CNc2ccc(F)cc2)cc(C)c1NC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 1/20 0.50
PPARA Q07869 6/20 0.46
KCNQ3 O43525 1/20 0.46
KCNQ2 O43526 1/20 0.46
KCNQ4 P56696 1/20 0.46
KCNQ5 Q9NR82 1/20 0.46
STING1 Q86WV6 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.44
GAA P10253 2/20 0.44
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
GFER P55789 1/20 0.44
HIF1A Q16665 3/20 0.44
HPGD P15428 2/20 0.44
FFAR1 O14842 2/20 0.44
HDAC4 P56524 1/20 0.43
MEF2D Q14814 1/20 0.43
ALDH1A1 P00352 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3605553 0.85 FFAR1 (0.52) PPARAMAPTHIF1AFFAR1HDAC4
SCHEMBL3613056 0.84 MEN1 (0.49) PPARASMN1; SMN2GAAMAPTALOX15
SCHEMBL3247396 0.84 FFAR1 (0.56) PPARAMAPTFFAR1NPC1RAB9A
SCHEMBL3591356 0.82 HIF1A (0.59) SMN1; SMN2GAAMAPTKDM4EHIF1A
SCHEMBL3099350 0.82 KCNQ3 (0.53) PPARAKCNQ3KCNQ2KCNQ4KCNQ5
SCHEMBL20641771 0.81 P4HTM (0.59) P4HTMPPARAKCNQ3KCNQ2KCNQ4
SCHEMBL18600165 0.77 CYP1A2 (0.55) P4HTMPPARAKCNQ3KCNQ2KCNQ4
SCHEMBL19690469 0.75 KCNQ3 (0.57) P4HTMPPARAKCNQ3KCNQ2KCNQ4
SCHEMBL3596698 0.74 PPARA (0.55) PPARAKCNQ3KCNQ2KCNQ4KCNQ5
SCHEMBL15348110 0.73 KCNQ3 (0.56) P4HTMPPARAKCNQ3KCNQ2KCNQ4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100063044-A1 SUBSTITUTED ANILINE DERIVATIVES H. LUNDBECK A/S (DK) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063044-A1 SUBSTITUTED ANILINE DERIVATIVES NDUFS3, NAT1, PRMT3 P4HTM 3058/4885PPARA 3106/4885KCNQ3 304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.